1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EYEPOINT PHARMACEUTICALS INC
EyePoint Pharmaceuticals Inc XNAS: EYPT

EyePoint Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its...

Read More
11.50 -0.10 (-0.86%)
194.12% Gain from 52W Low
201.7K
XNAS Volume

XNAS 29 Aug, 2025 11:50 AM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for EyePoint Pharmaceuticals Inc is on 03 Sep 2025 for the purpose of Cantor Global Healthcare Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
5.5 / 100
Momentum Score
Technically Bullish
73.9 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
34
1Yr Price target upside is 199%
12 analysts

12

S

10

W

1

O

3

T

SWOT Analysis

EyePoint Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..